Skip to main content

Table 3 Mortality hazard (HR) ratios and their 95% confidence intervals (CIs) comparing men who substituted spit tobacco use for cigarette smoking (“switchers”) with men who quit using tobacco use entirely (“quit entirely”) Cancer Prevention Study‐II, 1982–2002.

Death cause (ICD‐9 codes)* Tobacco use after smoking cessation No of deaths Death rate† Age‐adjusted HR (95% CI)‡ Multivariate‐adjusted HR (95% CI)§ Multivariate‐adjusted HR (95% CI)¶
All causes Quit entirely 23 358 1685 1.00 (referent) 1.00 (referent) 1.00 (referent)
Switcher 895 1994 1.19 (1.12 to 1.28) 1.13 (1.06 to 1.21) 1.08 (1.01 to 1.15)
Chew only 620 1944 1.17 (1.08 to 1.26) 1.12 (1.03 to 1.21) 1.05 (0.97 to 1.14)
Snuff only 154 2112 1.25 (1.06 to 1.46) 1.15 (0.98 to 1.35) 1.11 (0.94 to 1.30)
Chew and snuff 121 2114 1.27 (1.06 to 1.52) 1.17 (0.98 to 1.40) 1.16 (0.97 t o 1.39)
Lung cancer (162) Quit entirely 2384 128 1.00 (referent) 1.00 (referent) 1.00 (referent)
Switcher 155 233 1.92 (1.63 to 2.26) 1.76 (1.49 to 2.07) 1.46 (1.24 to 1.73)
Chew only 103 218 1.79 (1.47 to 2.18) 1.66 (1.36 to 2.02) 1.34 (1.10 to 1.64)
Snuff only 31 283 2.28 (1.60 to 3.25) 2.03 (1.42 to 2.91) 1.75 (1.22 to 2.50)
Chew and snuff 21 248 2.19 (1.42 to 3.36) 1.97 (1.28 to 3.03) 1.87 (1.21 to 2.87)
Coronary heart disease (410–414) Quit entirely 6075 386 1.00 (referent) 1.00 (referent) 1.00 (referent)
Switcher 252 482 1.28 (1.13 to 1.45) 1.19 (1.04 to 1.35) 1.13 (1.00 to 1.29)
Chew only 185 498 1.33 (1.15 to 1.54) 1.25 (1.08 to 1.45) 1.18 (1.02 to 1.37)
Snuff only 41 492 1.29 (0.95 to 1.75) 1.16 (0.85 to 1.58) 1.12 (0.82 to 1.53)
Chew and snuff 26 369 1.02 (0.70 to 1.51) 0.90 (0.61 to 1.33) 0.89 (0.60 to 1.31)
Stroke (430–438) Quit entirely 2336 123 1.00 (referent) 1.00 (referent) 1.00 (referent)
Switcher 93 151 1.29 (1.05 to 1.59) 1.28 (1.04 to 1.58) 1.24 (1.01 to 1.53)
Chew only 66 151 1.28 (1.00 to 1.63) 1.27 (0.99 to 1.63) 1.23 (0.96 to 1.57)
Snuff only 11 112 0.94 (0.52 to 1.69) 0.92 (0.51 to 1.66) 0.89 (0.49 to 1.62)
Chew and snuff 16 196 1.87 (1.14 to 3.05) 1.81 (1.11 to 2.97) 1.80 (1.10 to 2.95)
COPD (490–492, 496) Quit entirely 878 49 1.00 (referent) 1.00 (referent) 1.00 (referent)
Switcher 44 84 1.74 (1.29 to 2.36) 1.53 (1.13 to 2.08) 1.31 (0.96 to 1.78)
Chew only 32 86 1.75 (1.23 to 2.50) 1.53 (1.07 to 2.18) 1.26 (0.88 to 1.80)
Snuff only 9 92 2.19 (1.14 to 4.23) 1.94 (1.00 to 3.75) 1.68 (0.87 to 3.26)
Chew and snuff 3 63 1.03 (0.33 to 3.19) 0.89 (0.29 to 2.78) 0.91 (0.29 to 2.84)

COPD, chronic obstructive pulmonary disease; ICD‐9, International Classification of Diseases—ninth edition.

*Analysis for all causes excluded men who reported a history of cancer, heart disease, diabetes, stroke, chronic bronchitis or emphysema in 1982 (28%); analysis for lung cancer excluded men who reported a history of any cancer except non‐melanoma skin cancer in 1982 (6%); analysis for coronary heart disease excluded men who reported a history of heart disease or diabetes in 1982 (19%); analysis for stroke excluded men who reported a history of stroke in 1982 (2%); analysis for COPD excluded men who reported a history of chronic bronchitis or emphysema in 1982 (6%). “Chew and snuff” includes men who currently use both chewing tobacco and snuff, and men who currently use only one product and reported past use of the other product.

†Death rates are per 100 000 person‐years and are age‐standardised to the Cancer Prevention Study‐II male person‐year distribution.

‡From Cox proportional hazards models, adjusted for age only.

§From Cox proportional hazards models adjusted for age, race, educational level, body mass index, exercise level, alcohol consumption, employment type, employment status, fat consumption, fruit and vegetable intake and aspirin use.

¶From Cox proportional hazards models adjusted for age, number of cigarettes formerly smoked per day, number of years smoked cigarettes, age at which they quit smoking cigarettes, race, educational level, body mass index, exercise level, alcohol consumption, employment type, employment status, fat consumption, fruit and vegetable intake and aspirin use.